Cargando…
Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
There is an urgent need for new and better biomarker modalities to estimate the risk of recurrence within the luminal-like breast cancer (BC) population. Molecular diagnostic tests used in the clinic lack accuracy in identifying patients with early luminal BC who are likely to develop metastases. Th...
Autores principales: | Lambrechts, Yentl, Garg, Abhishek D., Floris, Giuseppe, Punie, Kevin, Neven, Patrick, Nevelsteen, Ines, Govaerts, Jannes, Richard, François, Laenen, Annouschka, Desmedt, Christine, Wildiers, Hans, Hatse, Sigrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575765/ https://www.ncbi.nlm.nih.gov/pubmed/37759086 http://dx.doi.org/10.1038/s41435-023-00220-z |
Ejemplares similares
-
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023) -
Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022) -
Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020) -
Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022) -
Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)